我要投票 冠昊生物GUANHAO在医疗器械行业中的票数:176
· 外 推 电 报 ·
2025-04-04 04:03:07 星期五

【冠昊生物GUANHAO是哪个国家的品牌?】

冠昊生物GUANHAO是什么牌子?「冠昊生物GUANHAO」是 冠昊生物科技股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人张永明在1999-10-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力冠昊生物GUANHAO品牌出海!通过在本页面挂载冠昊生物GUANHAO品牌的产品链接和联系邮箱,可以提高冠昊生物GUANHAO产品曝光!跨境电商爆单神器,目前只要100元/年哦~

冠昊生物科技股份有限公司(股票代码:300238,简称冠昊生物)是一家立足再生医学产业,拓展生命健康相关领域,嫁接全球技术资源和成果,面向中国市场进行贯通性产业化的专业化、平台化、生态化产业高科技上市企业。

冠昊生物不断投身于再生医学领域产业化的创新与开发,以生物材料技术和细胞与干细胞技术两大技术体系为支撑,坚持自主创新与国际技术相结合。1999年,建立天然生物材料处理技术平台并实现产业化,目前拥有国内外专利百余项,已上市产品有6种,在研产品数十种,涵盖神经外科、骨科、眼科、烧伤科、整形美容科、妇科等科室。2013年起,公司不断布局细胞与干细胞产业化平台,陆续开展人源组织工程化再生软骨移植治疗技术、免疫细胞储存等技术服务。2014年,冠昊生物与北京大学合作成立“北大冠昊干细胞与再生医学研究院”,立志成为国际化干细胞研究与临床转化平台。

冠昊生物愿与后来者分享创业经验,成立了集合各种资源的、有深度和广度的产业化转化平台——广东冠昊生命健康科技园,搭建专业的生命健康产业领域科技成果产业化转化的平台,吸纳、扶植众多生命健康领域的科技项目和小微企业来园区创业。


英文翻译:Guanhao Biotechnology Co., Ltd. (Stock Code: 300238, referred to as Guanhao biotechnology for short) is a high-tech listed enterprise that bases on the renewable medicine industry, expands the fields related to life and health, grafts the global technical resources and achievements, and carries out the through industrialization in the Chinese market. Guanhao biology has been continuously engaged in the innovation and development of industrialization in the field of regenerative medicine, supported by the two major technical systems of biomaterial technology and cell and stem cell technology, and adheres to the combination of independent innovation and international technology. In 1999, the natural biomaterial processing technology platform was established and industrialized. At present, it has more than 100 patents at home and abroad, 6 products have been listed, and dozens of products are under research, covering neurosurgery, orthopedics, ophthalmology, burn department, plastic and cosmetic department, gynecology and other departments. Since 2013, the company has continuously deployed the industrialization platform of cells and stem cells, and has successively carried out technical services such as human tissue engineering regeneration cartilage transplantation treatment technology, immune cell storage, etc. In 2014, Guanhao biology cooperated with Peking University to establish "Guanhao stem cell and Regenerative Medicine Research Institute of Peking University", aiming to become an international platform for stem cell research and clinical transformation. Guanhao biology is willing to share the entrepreneurial experience with the latecomers, set up Guangdong Guanhao life and health science and Technology Park, a deep and wide industrialization transformation platform integrating various resources, set up a professional platform for the industrialization of scientific and technological achievements in the field of life and health industry, and absorb and support many scientific and technological projects and small and micro enterprises in the field of life and health to start businesses in the park.

本文链接: https://www.waitui.com/brand/930424f51.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美国2月贸易逆差1227亿美元

美国商务部普查局4月3日发布数据,2月贸易逆差1227亿美元,预估为逆差1235亿美元,前值为逆差1314亿美元。(界面)

4分钟前

美股大型科技股盘前普跌,苹果跌超7%

36氪获悉,美股大型科技股盘前普跌,截至发稿,苹果、亚马逊跌超7%,特斯拉、Arm、英伟达跌超6%,Meta跌超5%,谷歌跌超4%,微软、奈飞跌超3%。

4分钟前

热门中概股美股盘前普跌,拼多多跌超6%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超6%,京东跌超5%,百度、爱奇艺、阿里巴巴、B站、蔚来跌超3%,理想汽车跌超2%,网易、腾讯音乐、微博跌超1%。

4分钟前

高测股份:控股股东张顼拟询价转让4.99%股份

36氪获悉,高测股份公告,公司控股股东张顼计划通过询价转让方式转让27,308,000股,占公司总股本的4.99%,转让原因为自身资金需求。出让方声明所持股份权属清晰,不存在限制或禁止转让情形,且不违反相关减持规定和承诺。本次询价转让的受让方需为具备相应定价能力和风险承受能力的机构投资者。本次询价转让的价格下限不低于发送认购邀请书之日(即2025年4月3日)前20个交易日高测股份股票交易均价的70%。

4分钟前

欧盟成员国拟表决对美关税反制措施

欧盟高级官员4月3日表示,欧盟成员国计划9日投票表决针对美方25%钢铝关税的反制措施。欧盟委员会负责贸易和经济安全等事务的委员马罗什·谢夫乔维奇表示,不合理的关税最终只会适得其反,欧盟将以冷静、有步骤且团结一致的方式作出回应。(新华社)

4分钟前

本页详细列出关于仁和可立克的品牌信息,含品牌所属公司介绍,仁和可立克所处行业的品牌地位及优势。
咨询